Cox analysis. by Edwin Aguirre-Milachay (15453672)

“…Survival was 97.5% at 48 hours, 85% at 7 days, 62% at 14 days, and 16.3% at the end of the study. Variables decreasing survival in patients with COVID-19 who were users of NFVC were age ≥ 60 years (HR = 2.23; 95% CI: 1.21–4.08), presence of arterial hypertension (HR = 1.87; 95% CI: 1.01–3.45), increased work of breathing on hospital admission (HR = 2.38; 95% CI: 1.31–4.35), and a ROX index (iROX) < 3.85 (HR = 1.71; 95% CI: 1.01–2.93).…”

Comparison of the laryngeal measures during vocalization between pwPD and controls. by Andrew Ma (4532494)

FACIT-Fatigue score normalization at baseline and after 16 weeks of pegcetacoplan treatment are shown for patients with PNH and mild/moderate anemia (hemoglobin ≥10.0 g/dL) in the... by Jens Panse (350046)

Fig 2 - by Jens Panse (350046)

Fig 1 - by Jens Panse (350046)

Fig 5 - by Jens Panse (350046)

Fig 3 - by Jens Panse (350046)

Protective Effect of Remote Limb Ischemic Perconditioning on the Liver Grafts of Rats with a Novel Model by Junjun Jia (704682)

“…<div><p>Background</p><p>Remote ischemic conditioning (RIC) is a known manual conditioning to decrease ischemic reperfusion injury (IRI) but not increase ischemic time. …”

Gene co-expression network analysis of the GSE263867 dataset. by Yaping Yuan (2734228)

Alcohol-induced fatalities and crude rates in the United States at the county level. by Tony Wong (779773)

Kaplan-Meier survival curve in patients using HFNC according to WOB at 12-24 hours. by Edwin Aguirre-Milachay (15453672)

Kaplan-Meier survival curve in patients using HFNC according to iROX. by Edwin Aguirre-Milachay (15453672)

Kaplan-Meier survival curve in patients using HFNC according to age. by Edwin Aguirre-Milachay (15453672)

Kaplan-Meier survival curve in patients using HFNC according to hypertension. by Edwin Aguirre-Milachay (15453672)

Kaplan-Meier survival curve in patients using HFNC according to PaO2/FiO2. by Edwin Aguirre-Milachay (15453672)

Characteristics of COVID-19 patients using high-flow nasal cannula according to mortality. by Edwin Aguirre-Milachay (15453672)

Kaplan-Meier survival curve in patients using HFNC according to IMV. by Edwin Aguirre-Milachay (15453672)

Kaplan-Meier survival curve in patients using HFNC according to WOB at admission. by Edwin Aguirre-Milachay (15453672)

Yearly crude rates normalized by their 1999 value. by Tony Wong (779773)

“…<p>Values below 1 indicate crude rate decreases relative to their 1999 value, those above 1 indicate increases. …”

Parameters and times related to the use of high-flow nasal cannula and mechanical ventilation according to mortality in patients with COVID-19. by Edwin Aguirre-Milachay (15453672)